Following the positive opinion received on November 24th from the French regulatory authority ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) in the treatment of lateral

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field